Human HIV Vaccine Trial Begins With BRILLIANT 011
South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.
Biovac R&D Lab to Drive Vaccine Manufacturing in Africa
Biovac R&D Lab opens in Cape Town, enhancing vaccine manufacturing capabilities for Africa with support from the Gates Foundation.
Child Brain Injury Treatment Breakthroughs in Cape Town
Learn about Cape Town's innovative research in traumatic child brain injury and its potential global impact on treatment.
Biovac Secures Deal to Produce Pneumonia Vaccine
Biovac secures a deal with Biological E to produce a pneumonia vaccine in Africa, promoting vaccine independence continent-wide.